Prevalência e factores de risco para Anemia Ferropénica e Ferropénia durante a gravidez : um estudo prospectivo by Gomes da Costa, Ana et al.
A
R
TIG
O
 O
R
IG
IN
A
L
514Revista Científica da Ordem dos Médicos          www.actamedicaportuguesa.com                                                                                                                
Prevalence and Risk Factors for Iron Deficiency Anemia 
and Iron Depletion During Pregnancy: A Prospective 
Study
Prevalência e Factores de Risco Para Anemia 
Ferropénica e Ferropénia Durante a Gravidez: Um 
Estudo Prospectivo
1. Departamento de Ginecologia, Obstetrícia e Medicina da Reprodução. Hospital de Santa Maria. Centro Hospitalar Lisboa Norte. Lisboa. Portugal.
2. Faculdade de Medicina. Universidade de Lisboa. Centro Académico de Medicina. Lisboa. Portugal.
 Autor correspondente: Ana Gomes da Costa. ana.ofgc@gmail.com
Recebido: 15 de julho de 2015 - Aceite: 08 de março de 2016 | Copyright © Ordem dos Médicos 2016
Ana Gomes da COSTA1, Sara VARGAS1, Nuno CLODE1,2, Luís M. GRAÇA1,2
Acta Med Port 2016 Sep;29(9):514-518  ▪  http://dx.doi.org/10.20344/amp.6808
RESUMO
Introdução: A anemia e a carência de ferro são problemas de saúde globais e são mais frequentes em grávidas, mulheres em idade 
reprodutiva e crianças. O objetivo deste trabalho consistiu na avaliação da prevalência de anemia ferropénica e dos fatores de risco 
associados à ferropénia, na primeira metade da gravidez, numa amostra da população portuguesa. 
Material e Métodos: Estudo prospetivo, conduzido num hospital terciário, que incluiu grávidas até à 20ª semana de gestação. Foram 
coletados dados demográficos, relativos à gravidez e foram determinados os níveis séricos de hemoglobina e de ferritina no sangue 
materno. Recorreu-se à análise de regressão logística de variáveis múltiplas para identificar potenciais fatores de risco para ferropénia.
Resultados: Foram incluídas 201 grávidas, das quais cinco (2,49%) tinham anemia. Para além disso, 77 grávidas (38,3%) tinham 
carência de ferro e 22 (10,9%) apresentaram ferropénia grave. A idade materna foi o único fator de risco identificado. O odds ratio foi 
de 12,99 (95% IC 2,41 - 70,0) para grávidas com idade inferior a 20 anos e de 2,09 (95% IC 1,05 - 4,14), para grávidas com idade 
superior a 30 anos.
Discussão e Conclusão: Na nossa amostra, a prevalência de anemia na primeira metade da gravidez foi inferior à reportada noutros 
estudos. No entanto, mais de 30% das grávidas apresentaram carência de ferro. A idade materna foi o único fator de risco identificado.
Palavras-chave: Anemia Ferropénica; Complicações Hematológicas na Gravidez; Factores de Risco; Ferro/metabolism; Gravidez; 
Prevalência.
ABSTRACT
Introduction: Anemia and iron deficiency during pregnancy are a worldwide concern and are more frequent among women of 
reproductive age, pregnant women, and young children. The aim of this study was to assess the prevalence of iron deficiency anemia 
and the risk factors for iron depletion during the first half of pregnancy, in a Portuguese population.
Material and Methods: A prospective study was conducted at a tertiary hospital and included pregnant women, until the 20th week of 
gestation. Data was collected regarding demographic and pregnancy features and hemoglobin and serum ferritin concentrations were 
determined. A multivariate logistic regression was performed to identify potential risk factors for iron deficiency.
Results: Two hundred and one women were included, from which five (2.49%) presented anemia. Additionally, 77 (38.3%) exhibited 
iron deficiency and 22 (10.9%) revealed severe iron depletion. Maternal age was the only risk factor identified. The odds ratio (OR) was 
equal to 12.99 (95% CI 2.41 - 70.0) for women under twenty years of age and 2.09 (95% CI 1.05 - 4.14) for women older than thirty 
years of age.
Discussion and Conclusion: The prevalence of maternal anemia in the first half of pregnancy was lower than in other studies. 
However, more than one-third of the women exhibited iron deficiency. With the exception of maternal age, no other risk factors were 
identified. 
Keywords: Anemia, Iron-Deficiency; Hematologic; Iron/metabolism; Pregnancy; Pregnancy Complications, Prevalence; Risk Factors.
INTRODUCTION
 Anemia and iron deficiency affect billions of people 
worldwide and are more common among women of 
reproductive age, pregnant women, and young children. 
Globally, anemia is found in more than 20% of pregnancies. 
The highest rates are found in developing countries, with 
an estimated prevalence of 55.8% and 41.6% in Africa and 
Asia, respectively.1-3 In developed countries, according to 
the World Health Organization (WHO), this percentage 
falls to 18%.1,4 In Portugal, following the Empire Study, the 
incidence of anemia is slightly higher (19.9%) and is more 
common in pregnancy.5
During pregnancy, anemia is defined as a hemoglobin 
(Hb) concentration < 11.0 g/dL in the first and third 
trimesters and Hb < 10.5 g/dL in the second trimester.6 
Multiple factors may lead to anemia during this period, 
namely nutritional deficiencies, hemolysis and abnormal 
hemoglobin synthesis, blood loss, defective iron absorption 
and metabolism, and chronic conditions.7
Iron-deficiency (ID) is the most common cause of 
anemia in pregnancy. The spectrum of ID ranges from iron 
depletion, to deficient erythropoiesis and to iron deficient 
anemia.6,8 The prevalence of ID can be 2 - 2.5 times that 
of iron deficiency anemia (IDA). The risk factors related 
to IDA include teenage pregnancy, high parity, multiple 
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pregnancies and reduced inter-pregnancy intervals.2,7 A 
previous study analysed the iron status of pre-pregnant 
women and concluded that 36.5% of these had low iron 
stores, therefore presenting a higher risk of becoming 
iron deficient during their pregnancy.8 Furthermore, iron 
requirements increase for pregnant women and are difficult 
to achieve by diet alone.1,3,6
Iron deficiency anemia has been linked to negative 
maternal-fetal outcomes. For mothers, these include 
reduced working and intellectual capacity, increased 
susceptibility to infection, higher risk of post-partum 
anemia and depression.2,9 The perinatal outcomes include 
premature delivery, small for gestational age infants, a 
highest risk of anemia and poor physical and mental growth 
during infancy.2,7,9-11 Therefore, the diagnosis of IDA and its 
treatment has a positive impact.2,9,11,12 Moreover, current 
guidelines recommend a daily iron supplementation of at 
least 60 mg of elemental iron after the 16th - 20th week of 
gestation or sooner if there are any risk factors.1,13,14
The iron status can be determined by a serum ferritin 
(SF) assay that has the highest sensitivity and specificity 
to diagnose iron deficiency.7,15 Serum ferritin identifies iron 
deficiency earlier than other biomarkers such as Hb and 
transferring saturation (TS) but can be increased in the 
presence of inflammation or infection. If SF is < 30 μg/L, 
there is a 90% certainty that the iron stores are depleted, 
even if there is no anemia. A value < 15 μg/L, provides clear 
evidence for IDA.7,9,11
The treatment of IDA depends on the severity of the 
anemia. In mild cases, the primary treatment includes oral 
iron therapy. In more severe cases, intravenous iron may 
be used as parenteral iron results in a faster increase in Hb 
levels. If a critical value of Hg is achieved, blood transfusion 
has to be considered.12,14,15
With this study we seek to assess the occurrence of 
anemia and iron deficiency in a Portuguese population, as 
well as the risk factors for iron deficiency during the first half 
of pregnancy.
MATERIAL AND METHODS
A prospective study was conducted between February 
2013 and September 2014 at the Department of Obstetrics 
and Gynecology of Hospital de Santa Maria, a tertiary 
university/public hospital in Lisbon, Portugal. In our Hospital, 
there are about 2,300 deliveries per year. The study was 
approved by the Hospital’s Ethics Committee (Protocol 
number 936/12). An informed consent was obtained before 
enrolment.
All women attending their first hospital visit for antenatal 
care at 20 weeks or less were invited to participate 
in the present study. Exclusion criteria included iron 
supplementation, clinical history of hematological disease, 
chronic inflammation, infection or malignancies, and blood 
transfusions in the previous 6 months.
At their first medical appointment, clinical and obstetric 
histories were thoroughly collected and venous blood 
samples were taken for a full blood count and serum 
ferritin determination. Serum ferritin was measured by 
quimiluminescent assay.
Baseline data was also collected, comprising maternal 
age, ethnic group, parity, body mass index (BMI), smoker 
status, level of education, single/multiple gestation and 
gestational age at the time when laboratory tests were 
performed. 
Table 1 - Demographic characteristics*
Age (years) 31.0 (14 - 45)
Race
Caucasian 168 (83.6%)
Black 33 (16.4%)
Parity
0 121 (60.2%)
         1 57 (28.4%)
2 13 (6.5%)
3 - 5 10 (5.0%)
Gestational age (weeks) 11.2  ± 3.1
Pregnancy
Simple 186 (92.5%)
Multiple 15 (7.5%)
BMI (kg/m2) 24.5 (16 - 45)
Origin of mother
Europe + North America 165 (82.1%)
Africa 28 (13.9%)
South America 8 (4.0%)
Education
Primary 12 (6.0%)
Lower secondary 30 (14.9%)
Upper secondary 71 (35.3%)
University degree 88 (43.8%)
Interpregnancy interval (n = 80)
< 1 year 8 (10%)
1 - 2 years 8 (10%)
≥ 2 years 64 (80%)
Smoking status
Smokers 47 (23.4%)
Non-smokers 154 (76.6%)
Nutritional status
Vegetarian 2 (1.0%)
Non-vegetarian 199 (99%)
* Values are given as median (range) or numbers (percentage) unless otherwise indicated.
BMI: Body mass index
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Anemia was defined as Hb < 11.0 g/dL in the first 
trimester (before the 14th week of pregnancy) and 10.5 g/dL 
in the second (from the 14th to the 27th week of pregnancy). 
Iron depletion was defined as a SF < 30 mg/L and severe 
iron depletion as a SF < 15 mg/L. Two groups of women were 
compared based on the concentration of SF: without iron 
deficiency (SF ≥ 30 mg/L) and with iron deficiency (SF < 30 
mg/L). The following potential risk factors were examined: 
age, race, parity, body mass index, multiple gestations, level 
of education and smoker status. For a secondary outcome 
of this study, a sub-analysis was conducted to analyse 
women with severe iron depletion (SF < 15 m/L). 
Statistical analysis was performed with SPSS software 
version 2.0 (SPSS Inc., Chicago, IL, USA). A sample size 
was calculated to evaluate the prevalence of maternal 
anemia, and, for a maximum error of 0.05, ninety women 
had to be enrolled in the study.
The Kolmogorov-Smirnoff test was used to assess the 
normality of the data distribution. Student’s t Test and Mann-
Whitney U test were performed to compare continuous 
variables. The Fisher’s exact test and Pearson X2 test were 
used to compare categorical variables. 
Multivariate logistic regression analysis was performed 
to analyse potential risk factors for decreased iron stores. 
p-value < 0.05 was considered to be statistically significant.
RESULTS
Two hundred and one women were included, whose 
demographic characteristics are shown in Table 1. The 
median of maternal age was 31 years and the mean 
gestational age at enrolment was 11.2 ± 3.1 weeks. The 
mean hemoglobin concentration at the baseline was 12.8 
± 0.9 g/dL and the median of serum ferritin was 39.0 mg/L 
(3.8 - 245.0 mg/L).
In the study group, the prevalence of maternal anemia 
was 2.49% (5/201). However, 38.3% (77 women) already 
showed decreased levels of iron (SF < 30 mg/L). Out of 
these, 10.9% (22 women) had severe iron depletion, 
defined as SF < 15 mg/L.
Overall, there were no statistically significant differences 
between women with normal SF and depleted iron stores 
regarding maternal age, race, parity, BMI, smoker status, 
university degree, multiple gestation and gestational age at 
enrolment in the study. The sub-analysis between women 
with normal SF and with severe iron deficiency (SF < 15 
mg/L) didn’t show any differences as well, except for the 
haemoglobin level, which was lower in the last group (Table 
2). 
However, the multivariate logistic regression analysis 
showed that the odds ratio for iron deficiency increased in 
younger and older women. The odds ratio (OR) was 12.99 
(95% CI 2.41 - 70.0) for women under twenty years of age 
and 2.09 (95% CI 1.05 - 4.14) for women over thirty years 
of age. In our study, race, parity, BMI, multiple gestation, 
level of education and smoker status were not linked to an 
increased risk of iron deficiency (Table 3).
DISCUSSION AND CONCLUSION
Anemia and iron status are important determinants 
of maternal and infant health and are linked to negative 
pregnancy outcomes.3 Data on maternal anemia and 
its predictors is limited in Portugal as few studies were 
published.
Our study group showcased a 2.5% prevalence of 
anemia, lower than the one reported in other studies,1,16-18 
with the exception of a Swiss study that also reported a 
low prevalence of IDA during pregnancy (3%).19 The lower 
prevalence of IDA may be due to the demographic features 
of our study group, which only included women until the 20th 
week of pregnancy. As anemia during pregnancy increases 
more than a 4-fold from the first to the third trimester, the 
prevalence of anemia would be probably higher in late 
pregnancy, in women without iron supplementation. 
As expected, the prevalence of iron depletion was 
higher than IDA. In the first half of the pregnancy, more 
than one-third of our study group had low serum ferritin 
Table 2 - Comparison of the demographic characteristics between groups: serum ferritin ≥ 30 μg/L vs serum ferritin < 30 μg/L and serum 
ferritin ≥ 30 μg/L vs serum ferritin < 15 μg/L*
Ferritin ≥ 30
n = 124 (61.7%) 
Ferritin < 30
n = 77 (38.3%) p-value
Ferritin < 15
n = 22 (10.9%) p-value
Age (years) 32 (14 - 45) 30 (16 - 45) 0.667 29 (17 - 41) 0.096
Race (caucasian) 103 (83.1%) 65 (84.4%) 0.956 19 (86.4%) 0.942
Parity (nuliparity) 79 (63.7%) 42 (54.5%) 0.253 13 (59.1%) 0.862
Gestational age (weeks) 11 (4 - 18.57) 10.14 (5.14 - 19) 0.402 9.86 (6.57 - 18) 0.413
Multiple pregnancy 9 (7.3%) 6 (7.8%) 0.892 2 (9.1%) 0.89
BMI (kg/m2) 24.6 (16.3 - 44.7) 23.8 (18 - 43.4) 0.745 22.5 (18.3 - 38.1) 0.245
Hb 1st Trimester 12.8 (10.9 - 15.1) 12.7 (10.2 - 15.3) 0.212 12.3 (10.2 - 14.6) 0.016
Education (university degree) 55 (44.4%) 33 (42.9%) 0.951 8 (36.4%) 0.643
Smoking status (smokers) 29 (23.4%) 18 (23.4%) 0.865 3 (13.6%) 0.519
* Data expressed as median (range) or n (%). BMI: Body mass index; Hb: Haemoglobin.
Costa AG, et al. Prevalence and risk factors for iron deficiency anemia and iron depletion during pregnancy, Acta Med Port 2016 Sep;29(9):514-518 
A
R
TI
G
O
 O
R
IG
IN
A
L
Revista Científica da Ordem dos Médicos          www.actamedicaportuguesa.com                                                                                                                517
Costa AG, et al. Prevalence and risk factors for iron deficiency anemia and iron depletion during pregnancy, Acta Med Port 2016 Sep;29(9):514-518 
concentrations (SF < 30 mg/L) and 11% had severe iron 
depletion. In agreement with former studies, our findings 
conclude that maternal age is a risk factor for iron deficiency 
in the first half of pregnancy. Women older than thirty-years-
old had a 2-fold higher risk of iron deficiency and women 
under twenty-years-old had almost a 13-fold higher risk for 
iron deficiency. No other risk factors were found among our 
study parameters, which also included race, body mass 
index, level of education and smoker status. We also did 
not find a correlation between parity and lower serum ferritin 
concentrations. Unexpectedly, the prevalence of IDA and 
iron deficiency didn’t differ between simple and multiple 
pregnancies. However, due to the small number of multiple 
pregnancies included (n = 15), these results should be 
interpreted with caution. 
These results are relevant given the lack of data 
regarding anemia during pregnancy in Portugal, and to 
alert clinicians to the high prevalence of iron depletion in 
pregnant women, becoming at risk of developing anemia. 
The best moment to evaluate maternal iron status is in 
the early stages of pregnancy, before the plasma is fully 
expanded. Also, in the first trimester, it may be beneficial 
to evaluate the serum ferritin, to identify women with iron 
depletion and at risk of anemia.6 A low SF may warrant an 
early intervention and iron status improvement with iron 
supplementation. The positive effects of adequate iron 
supplementation during pregnancy are well known and 
include improved birth weight and reduction in preterm 
labour and perinatal morbidity. These effects extend into the 
postnatal period with improved maternal Hb concentrations 
four to eight weeks postpartum.12,20,21
Nonetheless, clinicians should also be aware of the 
increased risk of adverse maternal and neonatal outcomes 
linked to excess of iron and high hemoglobin concentrations. 
Studies have found an increased risk of low birth weight, 
preterm birth and small for gestational age infants, while 
others have showed that iron supplementation in non-
anemic women did not affect birth weight.20,21 Therefore, iron 
supplementation in pre-pregnancy and early in pregnancy 
may be considered, only for women with low serum ferritin 
concentration and anemia.6,12,20
This study presents some limitations. It included only 
Table 3 - Multivariate logistic regression analysis of the factors associated to iron deficiency
Decreased iron stores*
Odds ratio 95% Confidence Interval
Age (years)
< 20 12.99 2.41 - 70.0
20 - 30 (reference category) 1 -
> 30 2.09 1.05 - 4.14
Race
Black 0.91 0.35 - 2.38
Parity
2 - 3 0.61 0.18 - 2.11
> 4 4.51 0.45 - 45.76
Body mass index
18.5 - 24 (reference category) 1 -
< 18.5 1.16 0.18 - 7.64
25 - 29 1.29 0.57 - 2.89
≥ 30 1.87 0.72 - 4.85
Multiple gestation 0.78 0.11 - 5.5
Education
University degree (reference category) 1 -
Primary 0.562 0.12 - 2.63
Lower secondary 1.43 0.53 - 3.87
Upper secondary 1.03 0.5 - 2.14
Smokers 0.99 0.47 - 2.12
* Serum ferritin < 30 μg/l
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fifteen multiple pregnancies which is probably insufficient 
to provide reliable conclusions regarding this group. As in 
most studies, we used a cut-off of 30 mg/L to define iron 
deficiency. However, lower cut-offs have been used (ex. SF 
< 20 mg/L), sustaining why the prevalence of iron deficiency 
in our study may be higher. To minimize this constraint a 
sub-analysis was performed to evaluate pregnant women 
with severe iron depletion (SF < 15 mg/L). 
Although SF is the best biochemical parameter for 
iron deficiency, a known limitation of this marker is that it 
increases with inflammation, infection or malignancy. Some 
authors believe that transferrin saturation (TS) should also 
be determined to identify errors, as its value doesn’t increase 
with inflammation. In addition, an assessment of C-reactive 
protein (CRP) levels would help to identify those cases. 
We didn’t determine the TS nor the CRP, as it would add 
additional costs to the study. However, the clinical history of 
each potential participant was thoroughly collected, prior to 
their enrolment, to exclude those with evidence of infection 
or inflammation. 
Although our sample includes healthy women with 
uncomplicated pregnancies surveyed at our prenatal 
consult, we should be cautioned when generalizing these 
findings to the general population. For that, more studies 
should be conducted, preferably multicentre, and in Health 
Centres in order to gather a larger group of eligible subjects.
In conclusion, our findings indicate that, although 
maternal anemia in the first half of pregnancy seems to be 
lower in Portugal than in other countries, more than one-
third of the study subjects had low ferritin concentrations 
and increased risk of anemia. Maternal age was the only risk 
factor identified, especially for teenage women, implying that 
iron depletion may affect all pregnant women, regardless 
of race, parity, body mass index, level of education and 
smoker status. Maternal anemia and iron deficiency are 
preventable risks factors for adverse maternal and birth 
outcomes, and iron supplementation may be considered not 
only after the 16th-20th week of pregnancy but also earlier 
if iron reserves are low. Despite our results, more studies 
should be conducted, 
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